Hans-Joachim Schmoll, MD, PhD, on Treatment Options in Locally Advanced Rectal Cancer
MedPage Today,
The PETACC 6 trial was launched in 2008 to assess the impact of adding oxaliplatin to the standard of care on 3-year disease-free…
Neoadjuvant 5-FU or Capecitabine Plus Radiation With or Without Oxaliplatin in Rectal Cancer Patients: A Phase III Randomized Clinical Trial
Overview of attention for article published in JNCI: Journal of the National Cancer Institute, September 2015
Altmetric Badge
About this Attention Score
-
In the top 5% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (95th percentile)
-
High Attention Score compared to outputs of the same age and source (83rd percentile)
Mentioned by
- news
- 1 news outlet
- 7 X users
- 1 Facebook page
- guideline
- 8 clinical guideline sources
Readers on
- mendeley
- 213 Mendeley